Novel mutation in FBN1 causes ectopia lentis and varicose great saphenous vein in one Chinese autosomal dominant family

被引:0
作者
Fu, Qing [1 ,7 ]
Liu, Peng [2 ]
Lu, Qingsheng [3 ]
Wang, Feng [4 ]
Wang, Hui [4 ]
Shen, Wei [5 ]
Xu, Fei [1 ]
Liu, Lin [6 ]
Sergeev, Yuri V. [8 ]
Sui, Ruifang [1 ]
机构
[1] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Ophthalmol, Beijing 100021, Peoples R China
[2] Second Mil Med Univ, Changhai Hosp, Dept Surg, Shanghai, Peoples R China
[3] Second Mil Med Univ, Changhai Hosp, Dept Vasc Surg, Shanghai, Peoples R China
[4] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[5] Second Mil Med Univ, Changhai Hosp, Dept Ophthalmol, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Renji Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China
[7] Fudan Univ, North Huashan Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China
[8] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA
来源
MOLECULAR VISION | 2014年 / 20卷
关键词
MARFAN-SYNDROME; FIBRILLIN-1; GENE; IDENTIFICATION; PHENOTYPE; GENOTYPE; PROBANDS; DOMAIN;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose: To identify genetic defects in a Chinese family with ectopia lentis (EL) and varicose great saphenous vein (GSV) and to analyze the correlations between phenotype and genotype. Methods: Twenty-two (12 affected subjects and ten unaffected subjects) among 53 members of a Chinese family underwent complete physical, ophthalmic, and cardiovascular examinations. Genomic DNA was extracted from the leukocytes in the subjects' peripheral blood. A minimum interval was achieved with linkage study and haplotype analysis. All 65 exons and the flanking intronic regions of fibrillin-1 (FBN1) were amplified with PCR and screened for mutations with direct Sanger sequencing. Molecular modeling was analyzed in an in silico study. Results: The linkage study showed a strong cosegregation signal on chromosome 15. The non-parametric linkage analysis yielded a maximum score of 29.1(p<0.00001), and the parametric logarithm of the odds (LOD) score was 3.6. The minimum interval of the shared haplotype was rs1565863-rs877228. The best candidate gene in this region was FBN1. A novel mutation, c.3928G>A, p.1310G>S in exon 31, was identified in FBN1 and cosegregated well in the family. We applied molecular modeling to show the effect of this mutation on the fibrillin-1 structure. The mutation significantly distorts the calcium coordination, decreases the binding of the calcium ion in that motif, and affects the local calcium-binding epidermal growth factor (cbEGF) interface that depends on Ca binding. Conclusions: FBN1-associated fibrillinopathies are a group of diseases with dynamic phenotype changes. Novel mutation p.1310G>S was first reported to cause Marfan syndrome (MFS). Our results expand the mutation spectrum in FBN1 and enhance our knowledge of genotype-phenotype correlations underlying FBN1 mutations.
引用
收藏
页码:812 / 821
页数:10
相关论文
共 28 条
  • [1] Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5
  • [2] Marfan syndrome in the third Millennium
    Collod-Béroud, G
    Boileau, C
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (11) : 673 - 681
  • [3] DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO
  • [4] 2-R
  • [5] Dong JM, 2012, MOL VIS, V18, P81
  • [6] Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations:: An international study
    Faivre, L.
    Collod-Beroud, G.
    Loeys, B. L.
    Child, A.
    Binquet, C.
    Gautier, E.
    Callewaert, B.
    Arbustini, E.
    Mayer, K.
    Arslan-Kirchner, M.
    Kiotsekoglou, A.
    Comeglio, P.
    Marziliano, N.
    Dietz, H. C.
    Halliday, D.
    Beroud, C.
    Bonithon-Kopp, C.
    Claustres, M.
    Muti, C.
    Plauchu, H.
    Robinson, P. N.
    Ades, L. C.
    Biggin, A.
    Benetts, B.
    Brett, M.
    Holman, K. J.
    De Backer, J.
    Coucke, P.
    Francke, U.
    De Paepe, A.
    Jondeau, G.
    Boileau, C.
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 81 (03) : 454 - 466
  • [7] The new Ghent criteria for Marfan syndrome: what do they change?
    Faivre, L.
    Collod-Beroud, G.
    Ades, L.
    Arbustini, E.
    Child, A.
    Callewaert, B. L.
    Loeys, B.
    Binquet, C.
    Gautier, E.
    Mayer, K.
    Arslan-Kirchner, M.
    Grasso, M.
    Beroud, C.
    Hamroun, D.
    Bonithon-Kopp, C.
    Plauchu, H.
    Robinson, P. N.
    De Backer, J.
    Couckek, P.
    Francke, U.
    Bouchot, O.
    Wolf, J. E.
    Stheneur, C.
    Hanna, N.
    Detaint, D.
    De Paepe, A.
    Boileau, C.
    Jondeauv, G.
    [J]. CLINICAL GENETICS, 2012, 81 (05) : 433 - 442
  • [8] FRANCKE U, 1995, AM J HUM GENET, V56, P1287
  • [9] Genetic Dissection of Marfan Syndrome and Related Connective Tissue Disorders: An Update 2012
    Hoffjan, S.
    [J]. MOLECULAR SYNDROMOLOGY, 2012, 3 (02) : 47 - 58
  • [10] Mutation spectrum of the fibrillin-1 (FBN1) gene in Taiwanese patients with Marfan syndrome
    Hung, Chia-Cheng
    Lin, Shin-Yu
    Lee, Chien-Nan
    Cheng, Hui-Yu
    Lin, Shuan-Pei
    Chen, Ming-Ren
    Chen, Chih-Ping
    Chang, Chien-Hui
    Lin, Chiou-Ya
    Yu, Chih-Chieh
    Chiu, Hsin-Hui
    Cheng, Wen-Fang
    Ho, Hong-Nerng
    Niu, Dau-Ming
    Su, Yi-Ning
    [J]. ANNALS OF HUMAN GENETICS, 2009, 73 : 559 - 567